These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 11306475)
1. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies. Engler S; Thiel C; Förster K; David K; Bredehorst R; Juhl H Cancer Res; 2001 Apr; 61(7):2968-73. PubMed ID: 11306475 [TBL] [Abstract][Full Text] [Related]
2. Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen. David K; Ollert MW; Vollmert C; Heiligtag S; Eickhoff B; Erttmann R; Bredehorst R; Vogel CW Cancer Res; 1999 Aug; 59(15):3768-75. PubMed ID: 10446994 [TBL] [Abstract][Full Text] [Related]
3. [Natural human IgM-antibodies in neuroblastoma therapy: preliminary findings of a phase I/II clinical trial]. Schmitt C; David K; Hiller J; Schrum J; Bredehorst R; Vogel CW; Löliger C; Erttmann R Klin Padiatr; 1999; 211(4):314-8. PubMed ID: 10472569 [TBL] [Abstract][Full Text] [Related]
4. [Establishing a new human neuroblastoma animal model for development of adjuvant therapy methods and for study of metastasis]. Engler S; Thiel C; David K; Juhl H Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):285-8. PubMed ID: 14518261 [TBL] [Abstract][Full Text] [Related]
5. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma. Fukuda M; Nozaki C; Ishiguro Y; Horibe K Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870 [TBL] [Abstract][Full Text] [Related]
6. Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM. David K; Heiligtag S; Ollert MW; Teppke M; Vogel CW; Bredehorst R Med Pediatr Oncol; 2001 Jan; 36(1):251-7. PubMed ID: 11464898 [TBL] [Abstract][Full Text] [Related]
7. Biologically relevant orthotopic neuroblastoma xenograft models: primary adrenal tumor growth and spontaneous distant metastasis. Khanna C; Jaboin JJ; Drakos E; Tsokos M; Thiele CJ In Vivo; 2002; 16(2):77-85. PubMed ID: 12073775 [TBL] [Abstract][Full Text] [Related]
8. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma. Geoerger B; van Beusechem VW; Opolon P; Morizet J; Laudani L; Lecluse Y; Barrois M; Idema S; Grill J; Gerritsen WR; Vassal G J Gene Med; 2005 May; 7(5):584-94. PubMed ID: 15651070 [TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice. Pastorino F; Brignole C; Marimpietri D; Sapra P; Moase EH; Allen TM; Ponzoni M Cancer Res; 2003 Jan; 63(1):86-92. PubMed ID: 12517782 [TBL] [Abstract][Full Text] [Related]
10. Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 gene. Corrias MV; Basso S; Meazza R; Musiani P; Santi L; Bocca P; Occhino M; Ferrini S; Pistoia V Cancer Gene Ther; 1998; 5(1):38-44. PubMed ID: 9476965 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of combination therapy using adeno-associated virus--interferon beta and trichostatin A in vitro and in a murine model of neuroblastoma. Hamner JB; Sims TL; Cutshaw A; Dickson PV; Rosati S; McGee M; Ng CY; Davidoff AM J Pediatr Surg; 2008 Jan; 43(1):177-82; discussion 182-3. PubMed ID: 18206478 [TBL] [Abstract][Full Text] [Related]
12. High level of stabilized angiostatin mediated by adenovirus delivery does not impair the growth of human neuroblastoma xenografts. Joseph JM; Bouquet C; Opolon P; Morizet J; Aubert G; Rössler J; Gross N; Griscelli F; Perricaudet M; Vassal G Cancer Gene Ther; 2003 Nov; 10(11):859-66. PubMed ID: 14605672 [TBL] [Abstract][Full Text] [Related]
13. Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans. David K; Ollert MW; Juhl H; Vollmert C; Erttmann R; Vogel CW; Bredehorst R Nat Med; 1996 Jun; 2(6):686-9. PubMed ID: 8640561 [TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591 [TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo. Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P Cancer Res; 2004 Oct; 64(20):7210-5. PubMed ID: 15492235 [TBL] [Abstract][Full Text] [Related]
16. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy. Pastorino F; Brignole C; Marimpietri D; Cilli M; Gambini C; Ribatti D; Longhi R; Allen TM; Corti A; Ponzoni M Cancer Res; 2003 Nov; 63(21):7400-9. PubMed ID: 14612539 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of human neuroblastoma. Prigione I; Corrias MV; Airoldi I; Raffaghello L; Morandi F; Bocca P; Cocco C; Ferrone S; Pistoia V Ann N Y Acad Sci; 2004 Dec; 1028():69-80. PubMed ID: 15650233 [TBL] [Abstract][Full Text] [Related]
18. Natural antibody against neuroblastoma among Japanese children with or without neuroblastoma. Fukuda M; Nozaki C; Ishiguro Y; Horibe K Cancer; 1999 Nov; 86(10):2166-70. PubMed ID: 10570448 [TBL] [Abstract][Full Text] [Related]
19. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production. Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905 [TBL] [Abstract][Full Text] [Related]
20. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]